While at the American Academy of Neurology annual meeting last month in Philadelphia, PA, I bumped into an old colleague from my neurohospitalist days in New London, CT. Christopher Gottschalk, MD, is Chief of the Division of General Neurology at Yale New Haven Hospital in New Haven, CT. Chris is an expert at headache management, and we got to talking about all the options available for migraine patients. He is really impressed with the effectiveness of the new calcitonin gene-related peptide (CGRP) receptor antagonists. Check out our discussion here. As always, your comments on much appreciated!